knowledge -WSS

knowledge

author：entertainment 2025-09-30 23:19:57 - browse：9465

Stoke Therapeutics is still seeking an effective dose for an experimental drug to treat a severe form of childhood epilepsy, following the release of updated data Tuesday that showed disappointing reductions in convulsive seizure activity.

In the latest look at an ongoing mid-stage study, three monthly injections of the Stoke drug, called STK-001, given at a 45-mg dose, resulted in a median 18% reduction in convulsive seizure activity, compared to baseline.

The new analysis was conducted on 16 children diagnosed with a rare form of epilepsy called Dravet syndrome. Last November, in six patients, the drug showed a median 55% reduction in seizure activity.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Stem cell treatment guidelines are released by FDA

leisure time

WSS

Wegovy cuts risk of cardiovascular events by 20%, study finds

Former Georgia lieutenant governor says he received grand jury subpoena

Ohioans vote in high

Listen: Biogen's potential pivot, & Illumina's next chapter

Hospitals use virtual reality to design more inclusive rooms for kids

Hospitals use virtual reality to design more inclusive rooms for kids

leisure time

knowledge

focus

Sports medicine is finally prioritizing gender equality

An Ebola outbreak presents a new mystery involving children

In Memoriam: Notable people who died in 2023

How generative AI is inspiring dreams of a health data revolution

Tori Bowie and the unacceptable rates of Black maternal death

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Jerome Adams on the need for new antivirals for Covid

Weighted lottery helped low

Moonlake's readout produced a cash windfall. Risks remain

Judge rejects Trump's counterclaim against E. Jean Carroll

explore

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

NIH nominee Bertagnolli will get October confirmation hearing

‘The Bear’ and hospitality in hospitals

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

In venture capital firm's success, lessons for turning crisis into profit

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

hotspot

explore

leisure time

leisure time